Table of Contents
| << Previous Issue | Feb 2007 (Vol: 2007, Issue: 80) | Next Issue >> |
- Section: Business Commentaries
-
Funding Research
- Section: Cartoons
-
Big Pharma
- Section: Deal Trackers
-
Junovan (mifamurtide)
- Section: Features
-
Seattle Genetics Boosts Cash Pile with January Deals
-
When Giants Meet: Bristol-Myers Squibb and AstraZeneca Form Alliance for Diabetes Drug
-
Nanotechnology for Drug Delivery: A Validated Technology?
-
Therapy Focus: Parkinson#8217;s Disease
- Section: General
-
Validation and Value: The Risk of RNAi Therapeutics
-
Elbion NV
- Section: Licensing
-
Boehringer and Ablynx Sign US$265 M Deal for Use of Nanobodies® in Alzheimer’s Disease
-
Bayer Schering Pharma Builds on Core Schering Technology in Neurodegenerative Diseases
- Section: Mergers & Acquisitions
-
Novartis to Divest Medical Nutrition Business Unit to Nestlé
- Section: Research & Development
-
Cytokinetics and Amgen Enter into Collaboration for Heart Failure
-
GlaxoSmithKline Further Improves its Biologics Capabilities
RSS